Global Enzalutamide Tablets Market Growth 2026-2032

March 2026 | 80 pages | ID: G294B806D707EN
LP Information

Abstracts

The global Enzalutamide Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Enzalutamide is an active pharmaceutical ingredient (API) used primarily in the treatment of prostate cancer. It is an androgen receptor inhibitor that works by blocking the action of androgens (male hormones like testosterone) on cancer cells, which can help slow the growth and spread of tumors.

United States market for Enzalutamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Enzalutamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Enzalutamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Enzalutamide Tablets players cover Astellas/Pfizer, AURISCO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Enzalutamide Tablets Industry Forecast” looks at past sales and reviews total world Enzalutamide Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Enzalutamide Tablets sales for 2026 through 2032. With Enzalutamide Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide Tablets industry.

This Insight Report provides a comprehensive analysis of the global Enzalutamide Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enzalutamide Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 40mg
• 80mg

Segmentation by Application:

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
• Castration- Resistant Prostate Cancer (NM-CRPC)

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Astellas/Pfizer
• AURISCO

Key Questions Addressed in this Report
What is the 10-year outlook for the global Enzalutamide Tablets market?
What factors are driving Enzalutamide Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide Tablets market opportunities vary by end market size?
How does Enzalutamide Tablets break out by Type, by Application?


The report requires updating with new data and is sent in 48 hours after order is placed.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Enzalutamide Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Enzalutamide Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Enzalutamide Tablets by Country/Region, 2021, 2025 & 2032
2.2 Enzalutamide Tablets Segment by Type
  2.2.1 40mg
  2.2.2 80mg
  2.2.3 Enzalutamide Tablets Sales by Type
    2.2.3.1 Global Enzalutamide Tablets Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Enzalutamide Tablets Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Enzalutamide Tablets Sale Price by Type (2021-2026)
2.3 Enzalutamide Tablets Segment by Application
  2.3.1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  2.3.2 Castration- Resistant Prostate Cancer (NM-CRPC)
  2.3.3 Enzalutamide Tablets Sales by Application
    2.3.3.1 Global Enzalutamide Tablets Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Enzalutamide Tablets Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Enzalutamide Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Enzalutamide Tablets Breakdown Data by Company
  3.1.1 Global Enzalutamide Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Enzalutamide Tablets Sales Market Share by Company (2021-2026)
3.2 Global Enzalutamide Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Enzalutamide Tablets Revenue by Company (2021-2026)
  3.2.2 Global Enzalutamide Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Enzalutamide Tablets Sale Price by Company
3.4 Key Manufacturers Enzalutamide Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Enzalutamide Tablets Product Location Distribution
  3.4.2 Players Enzalutamide Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Enzalutamide Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Enzalutamide Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Enzalutamide Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Enzalutamide Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Enzalutamide Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Enzalutamide Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Enzalutamide Tablets Sales Growth
4.4 APAC Enzalutamide Tablets Sales Growth
4.5 Europe Enzalutamide Tablets Sales Growth
4.6 Middle East & Africa Enzalutamide Tablets Sales Growth

5 AMERICAS

5.1 Americas Enzalutamide Tablets Sales by Country
  5.1.1 Americas Enzalutamide Tablets Sales by Country (2021-2026)
  5.1.2 Americas Enzalutamide Tablets Revenue by Country (2021-2026)
5.2 Americas Enzalutamide Tablets Sales by Type (2021-2026)
5.3 Americas Enzalutamide Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Enzalutamide Tablets Sales by Region
  6.1.1 APAC Enzalutamide Tablets Sales by Region (2021-2026)
  6.1.2 APAC Enzalutamide Tablets Revenue by Region (2021-2026)
6.2 APAC Enzalutamide Tablets Sales by Type (2021-2026)
6.3 APAC Enzalutamide Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Enzalutamide Tablets by Country
  7.1.1 Europe Enzalutamide Tablets Sales by Country (2021-2026)
  7.1.2 Europe Enzalutamide Tablets Revenue by Country (2021-2026)
7.2 Europe Enzalutamide Tablets Sales by Type (2021-2026)
7.3 Europe Enzalutamide Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Enzalutamide Tablets by Country
  8.1.1 Middle East & Africa Enzalutamide Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Enzalutamide Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Enzalutamide Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Enzalutamide Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide Tablets
10.3 Manufacturing Process Analysis of Enzalutamide Tablets
10.4 Industry Chain Structure of Enzalutamide Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Enzalutamide Tablets Distributors
11.3 Enzalutamide Tablets Customer

12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE TABLETS BY GEOGRAPHIC REGION

12.1 Global Enzalutamide Tablets Market Size Forecast by Region
  12.1.1 Global Enzalutamide Tablets Forecast by Region (2027-2032)
  12.1.2 Global Enzalutamide Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Enzalutamide Tablets Forecast by Type (2027-2032)
12.7 Global Enzalutamide Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Astellas/Pfizer
  13.1.1 Astellas/Pfizer Company Information
  13.1.2 Astellas/Pfizer Enzalutamide Tablets Product Portfolios and Specifications
  13.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Astellas/Pfizer Main Business Overview
  13.1.5 Astellas/Pfizer Latest Developments
13.2 AURISCO
  13.2.1 AURISCO Company Information
  13.2.2 AURISCO Enzalutamide Tablets Product Portfolios and Specifications
  13.2.3 AURISCO Enzalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 AURISCO Main Business Overview
  13.2.5 AURISCO Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. EnzalutamideTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. EnzalutamideTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40mg
Table 4. Major Players of 80mg
Table 5. Global EnzalutamideTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global EnzalutamideTablets Sales Market Share by Type (2021-2026)
Table 7. Global EnzalutamideTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global EnzalutamideTablets Revenue Market Share by Type (2021-2026)
Table 9. Global EnzalutamideTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global EnzalutamideTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global EnzalutamideTablets Sale Market Share by Application (2021-2026)
Table 12. Global EnzalutamideTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global EnzalutamideTablets Revenue Market Share by Application (2021-2026)
Table 14. Global EnzalutamideTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global EnzalutamideTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global EnzalutamideTablets Sales Market Share by Company (2021-2026)
Table 17. Global EnzalutamideTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global EnzalutamideTablets Revenue Market Share by Company (2021-2026)
Table 19. Global EnzalutamideTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers EnzalutamideTablets Producing Area Distribution and Sales Area
Table 21. Players EnzalutamideTablets Products Offered
Table 22. EnzalutamideTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global EnzalutamideTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global EnzalutamideTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global EnzalutamideTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global EnzalutamideTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global EnzalutamideTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global EnzalutamideTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global EnzalutamideTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global EnzalutamideTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas EnzalutamideTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas EnzalutamideTablets Sales Market Share by Country (2021-2026)
Table 35. Americas EnzalutamideTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas EnzalutamideTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas EnzalutamideTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC EnzalutamideTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC EnzalutamideTablets Sales Market Share by Region (2021-2026)
Table 40. APAC EnzalutamideTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC EnzalutamideTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC EnzalutamideTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe EnzalutamideTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe EnzalutamideTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe EnzalutamideTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe EnzalutamideTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa EnzalutamideTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa EnzalutamideTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa EnzalutamideTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa EnzalutamideTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of EnzalutamideTablets
Table 52. Key Market Challenges & Risks of EnzalutamideTablets
Table 53. Key Industry Trends of EnzalutamideTablets
Table 54. EnzalutamideTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. EnzalutamideTablets Distributors List
Table 57. EnzalutamideTablets Customer List
Table 58. Global EnzalutamideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global EnzalutamideTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas EnzalutamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas EnzalutamideTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC EnzalutamideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC EnzalutamideTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe EnzalutamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe EnzalutamideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa EnzalutamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa EnzalutamideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global EnzalutamideTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global EnzalutamideTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global EnzalutamideTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global EnzalutamideTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas/Pfizer Basic Information, EnzalutamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas/Pfizer EnzalutamideTablets Product Portfolios and Specifications
Table 74. Astellas/Pfizer EnzalutamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas/Pfizer Main Business
Table 76. Astellas/Pfizer Latest Developments
Table 77. AURISCO Basic Information, EnzalutamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. AURISCO EnzalutamideTablets Product Portfolios and Specifications
Table 79. AURISCO EnzalutamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AURISCO Main Business
Table 81. AURISCO Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of EnzalutamideTablets
Figure 2. EnzalutamideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EnzalutamideTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global EnzalutamideTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. EnzalutamideTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. EnzalutamideTablets Sales Market Share by Country/Region (2025)
Figure 10. EnzalutamideTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40mg
Figure 12. Product Picture of 80mg
Figure 13. Global EnzalutamideTablets Sales Market Share by Type in 2026
Figure 14. Global EnzalutamideTablets Revenue Market Share by Type (2021-2026)
Figure 15. EnzalutamideTablets Consumed in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Figure 16. Global EnzalutamideTablets Market: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (2021-2026) & (K Units)
Figure 17. EnzalutamideTablets Consumed in Castration- Resistant Prostate Cancer (NM-CRPC)
Figure 18. Global EnzalutamideTablets Market: Castration- Resistant Prostate Cancer (NM-CRPC) (2021-2026) & (K Units)
Figure 19. Global EnzalutamideTablets Sale Market Share by Application (2025)
Figure 20. Global EnzalutamideTablets Revenue Market Share by Application in 2026
Figure 21. EnzalutamideTablets Sales by Company in 2026 (K Units)
Figure 22. Global EnzalutamideTablets Sales Market Share by Company in 2026
Figure 23. EnzalutamideTablets Revenue by Company in 2026 ($ millions)
Figure 24. Global EnzalutamideTablets Revenue Market Share by Company in 2026
Figure 25. Global EnzalutamideTablets Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global EnzalutamideTablets Revenue Market Share by Geographic Region in 2026
Figure 27. Americas EnzalutamideTablets Sales 2021-2026 (K Units)
Figure 28. Americas EnzalutamideTablets Revenue 2021-2026 ($ millions)
Figure 29. APAC EnzalutamideTablets Sales 2021-2026 (K Units)
Figure 30. APAC EnzalutamideTablets Revenue 2021-2026 ($ millions)
Figure 31. Europe EnzalutamideTablets Sales 2021-2026 (K Units)
Figure 32. Europe EnzalutamideTablets Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa EnzalutamideTablets Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa EnzalutamideTablets Revenue 2021-2026 ($ millions)
Figure 35. Americas EnzalutamideTablets Sales Market Share by Country in 2026
Figure 36. Americas EnzalutamideTablets Revenue Market Share by Country (2021-2026)
Figure 37. Americas EnzalutamideTablets Sales Market Share by Type (2021-2026)
Figure 38. Americas EnzalutamideTablets Sales Market Share by Application (2021-2026)
Figure 39. United States EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC EnzalutamideTablets Sales Market Share by Region in 2026
Figure 44. APAC EnzalutamideTablets Revenue Market Share by Region (2021-2026)
Figure 45. APAC EnzalutamideTablets Sales Market Share by Type (2021-2026)
Figure 46. APAC EnzalutamideTablets Sales Market Share by Application (2021-2026)
Figure 47. China EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. India EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe EnzalutamideTablets Sales Market Share by Country in 2026
Figure 55. Europe EnzalutamideTablets Revenue Market Share by Country (2021-2026)
Figure 56. Europe EnzalutamideTablets Sales Market Share by Type (2021-2026)
Figure 57. Europe EnzalutamideTablets Sales Market Share by Application (2021-2026)
Figure 58. Germany EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 59. France EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 60. UK EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa EnzalutamideTablets Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa EnzalutamideTablets Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa EnzalutamideTablets Sales Market Share by Application (2021-2026)
Figure 66. Egypt EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries EnzalutamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of EnzalutamideTablets in 2026
Figure 72. Manufacturing Process Analysis of EnzalutamideTablets
Figure 73. Industry Chain Structure of EnzalutamideTablets
Figure 74. Channels of Distribution
Figure 75. Global EnzalutamideTablets Sales Market Forecast by Region (2027-2032)
Figure 76. Global EnzalutamideTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global EnzalutamideTablets Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global EnzalutamideTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global EnzalutamideTablets Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global EnzalutamideTablets Revenue Market Share Forecast by Application (2027-2032)